Gadolinium-Based Nanoparticles Sensitize Ovarian Peritoneal Carcinomatosis to Targeted Radionuclide Therapy.
Garcia-Prada CD, Carmes L, Atis S, Parach A, Bertolet A, Jarlier M, Poty S, Garcia DS, Shin WG, Du Manoir S, Schuemann J, Tillement O, Lux F, Constanzo J, Pouget JP.
Garcia-Prada CD, et al. Among authors: schuemann j.
J Nucl Med. 2023 Dec 1;64(12):1956-1964. doi: 10.2967/jnumed.123.265418.
J Nucl Med. 2023.
PMID: 37857502
Free PMC article.